Literature DB >> 29280261

Deproteinized bovine bone matrix induces osteoblast differentiation via macrophage polarization.

Miusi Shi1,2, Can Wang1, Yulan Wang1, Cuizhu Tang1, Richard J Miron3, Yufeng Zhang1,2.   

Abstract

Bone grafts are widely used in bone regeneration to increase the speed and quality of new bone formation. While they are routinely characterized based on their biocompatible and bioactive properties, they also exert a profound impact on host immune responses, which in turn can display a significant effect on the healing and repair process. In this study, we investigated the role of macrophage behavior on deproteinized bovine bone matrix (DBBM, BioOss) to investigate their impact on creating either a pro- or anti-inflammatory microenvironment for tissue integration. RT-PCR and immunofluorescence staining results demonstrated the ability for RAW 264.7 cells to polarize toward M2 wound-healing macrophages in response to DBBM and positive control (IL-4). Interestingly, significantly higher expression of interleukin-10 and higher number of multinucleated giant cells (MNGCs) was observed in the DBBM group. Thereafter, conditioned media (CM) from macrophages cultured with DBBM seeded with MC3T3-E1 cells demonstrated a marked increase in osteoblast differentiation. Noteworthy, this effect was reversed by blocking IL10 with addition of IL10 antibody to CM from the DBBM macrophages. Furthermore, the use of dendritic cell specific transmembrane protein (DC-STAMP)-knockout to inhibit MNGC formation in the DBBM group resulted in a significant reduction in osteoblast differentiation, indication a pivotal role for MNGCs in biomaterials-induced osteogenesis. The results from this study indicate convincingly that the immune response of macrophages towards DBBM has a potent effect on osteoblast differentiation. Furthermore, DBBM promoted macrophage fusion and polarization towards an M2 wound-healing phenotype, further created a microenvironment favoring biomaterial-induced osteogenesis.
© 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1236-1246, 2018. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  OsteoMacs; bone graft; deproteinized bovine bone matrix; immune cells; macrophage polarization; osteal macrophages

Mesh:

Substances:

Year:  2018        PMID: 29280261     DOI: 10.1002/jbm.a.36321

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Three-Dimensional Cartilage Regeneration Using Engineered Cartilage Gel With a 3D-Printed Polycaprolactone Framework.

Authors:  Gaoyang Wu; Lixing Lu; Zheng Ci; Yahui Wang; Runjie Shi; Guangdong Zhou; Shengli Li
Journal:  Front Bioeng Biotechnol       Date:  2022-05-24

2.  Macrophage polarization in periodontal ligament stem cells enhanced periodontal regeneration.

Authors:  Jiaying Liu; Bin Chen; Jun Bao; Yangheng Zhang; Lang Lei; Fuhua Yan
Journal:  Stem Cell Res Ther       Date:  2019-11-15       Impact factor: 6.832

3.  Macrophage Control of Incipient Bone Formation in Diabetic Mice.

Authors:  Miya Kang; Ghadeer Thalji; Chun-Chieh Huang; Sajjad Shirazi; Yu Lu; Sriram Ravindran; Lyndon F Cooper
Journal:  Front Cell Dev Biol       Date:  2021-01-25

Review 4.  Communications Between Bone Marrow Macrophages and Bone Cells in Bone Remodeling.

Authors:  Kaixuan Chen; Yurui Jiao; Ling Liu; Mei Huang; Chen He; Wenzhen He; Jing Hou; Mi Yang; Xianghang Luo; Changjun Li
Journal:  Front Cell Dev Biol       Date:  2020-12-22

Review 5.  Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis.

Authors:  Chen Hao Lo; Conor C Lynch
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-18       Impact factor: 5.555

6.  In Vitro Comparison of Macrophage Polarization and Osteoblast Differentiation Potentials between Granules and Block Forms of Deproteinized Bovine Bone Mineral.

Authors:  Masako Fujioka-Kobayashi; Simon D Marjanowski; Michihide Kono; Hiroki Katagiri; Richard J Miron; Benoit Schaller
Journal:  Materials (Basel)       Date:  2020-06-12       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.